Avid Bioservices Inc (NASDAQ: CDMO) stock closed at $4.76 on 11/27/23 after a major decline of -13.2%. The stock has declined -8.0% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CDMO is expected to continue to be Value Creation neutral.
Avid Bioservices has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock's attractiveness. Avid Bioservices has a very low Appreciation Score of 11 and a very low Power Rating of 0, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.